Insmed’s Brensocatib Enters Trial as Possible COVID-19 Treatment By Sam | April 23, 2020 Insmed is sponsoring a clinical trial in the UK of its bronchial drug Brensocatib as a potential COVID-19 treatment. Source: Drug Industry Daily Posted in Drug Industry Daily